2025 · 3rd Quarter (July 1 - Sep 30)
Filed by CROSSROADS STRATEGIES, LLC.
Open official filingSource-reported fields
Literal source text
Issues related to overdose reversal products including Naloxone; FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.5304/S.2587); FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.5342/S.2354).
Literal federal measure citations: H.R.5304, S.2587, H.R.5342, S.2354
Medicaid policies related to substance use disorder; H.R.1, One Big Beautiful Bill Act (P.L.119-21).
Literal federal measure citations: H.R.1
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
